Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-04-30T10:33:44.425Z Has data issue: false hasContentIssue false
  • English
  • Français

Spillover Effects of the Opioid Epidemic on Consumer Finance

Published online by Cambridge University Press:  24 November 2022

Mark Jansen Open the ORCID record for Mark Jansen [Opens in a new window]
Mark Jansen*
Affiliation:
University of Utah Eccles School of Business
*
mark.jansen@eccles.utah.edu
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

I examine the impact of the opioid epidemic on subprime auto lending. Using a difference-in-differences framework, I find that county-level increases in opioid abuse cause an increase in loan defaults. Moreover, I find that traditional credit scoring attributes (e.g., FICO score) fail to predict loan performance deterioration associated with opioid addiction. The weak predictive performance of traditional credit measures and the resulting higher default rates generate a negative externality for borrowers in opioid-afflicted areas, as evidenced by 5.7% higher loan costs for subprime borrowers.

Type
Research Article
Information
Journal of Financial and Quantitative Analysis , Volume 58 , Issue 6 , September 2023 , pp. 2365 - 2386
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the Michael G. Foster School of Business, University of Washington

Footnotes

For helpful comments, the author thanks an anonymous reviewer, Mara Faccio (the editor), John Griffin, Marlene Plumlee, Matt Ringgenberg, as well as seminar participants at the 2019 WFA Annual Meeting, 2020 IBEFA Annual Meeting, 2019 Financial Intermediation Research Society (FIRS) conference, 2020 SFS Cavalcade, 2019 UT Dallas Fall Finance Conference, Brigham Young University, Caltech, U.S. Securities and Exchange Commission (SEC), and the University of Utah. The author declares that he has no relevant or material financial interests that relate to the research described in this article.

References

Akerlof, G. A. “The Market for ‘Lemons’: Quality Uncertainty and the Market Mechanism.” Journal of Financial Economics, 84 (1970), 488–500.Google Scholar
Aliprantis, D., and Schweitzer, M. E.. “Opioids and the Labor Market.” Working Paper, Federal Reserve Bank of Cleveland (2018).Google Scholar
Anenberg, E., and Kung, E.. “Estimates of the Size and Source of Price Declines Due to Nearby Foreclosures.” American Economic Review, 104 (2014), 2527–2551.Google Scholar
Bachhuber, M. A.; Saloner, B.; Cunningham, C. O.; and Barry, C. L.. “Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999–2010.” JAMA Internal Medicine, 174 (2014), 1668–1673.Google Scholar
Bauman, V., and Lopez, I.. “The Opioid Crisis, Fueled by Covid, Is Worse Than Ever.” Bloomberg Businessweek (2021).Google Scholar
Bernheim, B. D., and Rangel, A.. “Addiction and Cue-Triggered Decision Processes.” American Economic Review, 94 (2004), 1558–1590.Google ScholarPubMed
Bickel, W. K.; Madden, G. J.; and Petry, N. M.. “The Price of Change: The Behavioral Economics of Drug Dependence.” Behavior Therapy, 29 (1998), 545–565.Google Scholar
Bickel, W. K., and Marsch, L. A.. “Toward a Behavioral Economic Understanding of Drug Dependence: Delay Discounting Processes.” Addiction, 96 (2001), 73–86.Google Scholar
Bricker, J.; Dettling, L. J.; Henriques, A.; Hsu, J. W.; Jacobs, L.; Moore, K. B.; Pack, S.; Sabelhaus, J.; Thompson, J.; and Windle, R. A.. “Changes in US Family Finances from 2013 to 2016: Evidence from the Survey of Consumer Finances.” Federal Reserve Bulletin, 103 (2017), 1.Google Scholar
Campbell, J. Y.; Giglio, S.; and Pathak, P.. “Forced Sales and House Prices.” American Economic Review, 101 (2011), 2108–2131.Google Scholar
Case, A., and Deaton, A.. Deaths of Despair and the Future of Capitalism. Princeton, NJ: Princeton University Press (2020).Google Scholar
Centers for Disease Control and Prevention. “Opioid Overdose: Understanding the Epidemic.” Technical Report, National Institute on Drug Abuse (2018a), available at https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates.Google Scholar
Centers for Disease Control and Prevention. “U.S. Drug Overdose Deaths Continue to Rise; Increase Fueled by Synthetic Opioids.” Technical Report, CDC (2018b).Google Scholar
Centers for Disease Control and Prevention. “Drug Overdose Deaths,” available at https://www.cdc.gov/nchs/hus/topics/drug-overdose-deaths.htm (2021).Google Scholar
Cohn, J. B., and Wardlaw, M. I.. “Financing Constraints and Workplace Safety.” Journal of Finance, 71 (2016), 2017–2058.Google Scholar
Council of Economic Advisers. “Council of Economic Advisers Report: The Underestimated Cost of the Opioid Crisis.” Technical Report, White House Council of Economic Advisers (2017).Google Scholar
Currie, J.; Jin, J. Y.; and Schnell, M.. “US Employment and Opioids: Is there a Connection?” NBER Technical Report (2018).Google Scholar
Cutler, D. M., and Glaeser, E.. “What Explains Differences in Smoking, Drinking, and Other Health-Related Behaviors?” American Economic Review, 95 (2005), 238–242.Google ScholarPubMed
Dobbie, W., and Song, J.. “Debt Relief and Debtor Outcomes: Measuring the Effects of Consumer Bankruptcy Protection.” American Economic Review, 105 (2015), 1272–1311.Google Scholar
Florence, C.; Luo, F.; Xu, L.; and Zhou, C.. “The Economic Burden of Prescription Opioid Overdose, Abuse and Dependence in the United States, 2013.” Medical Care, 54 (2016), 901.Google Scholar
Goodell, J. W. “COVID-19 and Finance: Agendas for Future Research.” Finance Research Letters, 35 (2020), 101512.Google ScholarPubMed
Gul, F., and Pesendorfer, W.. “Harmful Addiction.” Review of Economic Studies, 74 (2007), 147–172.Google Scholar
Hammersley, R.; Forsyth, A.; Morrison, V.; and Davies, J. B.. “The Relationship between Crime and Opioid Use.” British Journal of Addiction, 84 (1989), 1029–1043.Google ScholarPubMed
Harris, M. C.; Kessler, L. M.; Murray, M. N.; and Glenn, B.. “Prescription Opioids and Labor Market Pains the Effect of Schedule II Opioids on Labor Force Participation and Unemployment.” Journal of Human Resources, 55 (2020), 1319–1364.Google Scholar
Hill, K. P. “Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.” JAMA, 313 (2015), 2474–2483.Google ScholarPubMed
Himmelstein, D. U.; Thorne, D.; Warren, E.; and Woolhandler, S.. “Medical Bankruptcy in the United States, 2007: Results of a National Study.” American Journal of Medicine, 122 (2009), 741–746.Google ScholarPubMed
Jefferies, W. “First Mortgage Originations Continue Steady Rise, Reaching over $680 Billion in Total Balance.” Technical Report, Equifax (2018).Google Scholar
Kirby, K. N.; Petry, N. M.; and Bickel, W. K.. “Heroin Addicts Have Higher Discount Rates for Delayed Rewards than Non-Drug-Using Controls.” Journal of Experimental Psychology, 128 (1999), 78.Google ScholarPubMed
Krueger, A. B. “Where Have All the Workers Gone? An Inquiry into the Decline of the US Labor Force Participation Rate.” Brookings Papers on Economic Activity (2017), 1–87.Google Scholar
Levitt, S. D., and Porter, J.. “How Dangerous Are Drinking Drivers?” Journal of Political Economy, 109 (2001), 1198–1237.Google Scholar
Madden, G. J.; Petry, N. M.; Badger, G. J.; and Bickel, W. K.. “Impulsive and Self-Control Choices in Opioid-Dependent Patients and Non-Drug-Using Control Patients: Drug and Monetary Rewards.” Experimental and Clinical Psychopharmacology, 5 (1997), 256.Google ScholarPubMed
Mahoney, N. “Bankruptcy as Implicit Health Insurance.” American Economic Review, 105 (2015), 710–746.Google ScholarPubMed
Mian, A.; Sufi, A.; and Trebbi, F.. “Foreclosures, House Prices, and the Real Economy.” Journal of Finance, 70 (2015), 2587–2634.Google Scholar
Ouimet, P.; Simintzi, E.; and Ye, K.. “The Impact of the Opioid Crisis on Firm Value and Investment.” Working Paper, University of North Carolina at Chapel Hill (2020).Google Scholar
Pacula, R. L.; Kilmer, B.; Grossman, M.; and Chaloupka, F. J.. “Risks and Prices: The Role of User Sanctions in Marijuana Markets.” BE Journal of Economic Analysis & Policy, 10 (2010), art11.Google ScholarPubMed
Pacula, R. L.; Powell, D.; Heaton, P.; and Sevigny, E. L.. “Assessing the Effects of Medical Marijuana Laws on Marijuana Use: The Devil Is in the Details.” Journal of Policy Analysis and Management, 34 (2015), 7–31.Google ScholarPubMed
Park, S., and Powell, D.. “Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?” Journal of Health Economics, 76 (2021), 102430.Google ScholarPubMed
Powell, D.; Pacula, R. L.; and Jacobson, M.. “Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?” Journal of Health Economics, 58 (2018), 29–42.Google ScholarPubMed
Reiman, A.; Welty, M.; and Solomon, P.. “Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report.” Cannabis and Cannabinoid Research, 2 (2017), 160–166.Google ScholarPubMed
Stiglitz, J. E., and Weiss, A.. “Credit Rationing in Markets with Imperfect Information.” American Economic Review, 71 (1981), 393–410.Google Scholar
Xue, S.; Zhang, B.; and Zhao, X.. “Brain Drain: The Impact of Air Pollution on Firm Performance.” Journal of Environmental Economics and Management, 110 (2021), 102546.Google Scholar
Zabritski, M. State of the Automotive Finance Market. Second Quarter. Experian (2018).Google Scholar
Zedler, B. K.; Saunders, W. B.; Joyce, A. R.; Vick, C. C.; and Murrelle, E. L.. “Validation of a Screening Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in a US Commercial Health Plan Claims Database.” Pain Medicine, 19 (2017), 68–78.Google Scholar
Supplementary material: PDF

Jansen supplementary material

Jansen supplementary material

Download Jansen supplementary material(PDF)
PDF 285.4 KB